The number of employees laid off dropped year over year during the first quarter. BioSpace recaps the five largest layoffs, ...

Listen to this article Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and ...

Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical ...

Is the biotech job market improving in 2025? Explore the latest trends and opportunities in the industry after a challenging ...

Colossal Biosciences said it brought back the dire wolf, which has been extinct for over 12,000 years. Here's how they said ...

Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...

UNC Pembroke is offering a free, two-week bioprocessing training course to help students and community members prepare for ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Roche’s reorganization of Spark Therapeutics is coming more into focus, with nearly 300 employees being let go by the end of ...

CANFIELD — Vivek Ramaswamy, the 2026 Republican Party’s gubernatorial front-runner, told a crowd of close to about 740 at the ...

CANFIELD — Vivek Ramaswamy, the 2026 Republican Party’s gubernatorial front-runner, told a crowd of about 740 at the Mahoning ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...